Gilmour J S, Hansen W R, Miller H C, Keelan J A, Sato T A, Mitchell M D
Department of Pharmacology and Clinical Pharmacology, University of Auckland, School of Medicine, 85 Park Road, Grafton, Auckland, New Zealand.
J Mol Endocrinol. 1998 Dec;21(3):317-25. doi: 10.1677/jme.0.0210317.
Increased prostaglandin biosynthesis during intrauterine infection may be a possible mechanism by which preterm labour is initiated. Inflammatory cytokines and growth factors are known to stimulate prostaglandin production through an increase in prostaglandin endoperoxide H synthase (PGHS)-2 synthesis and activity. Interleukin-4 (IL-4), an anti-inflammatory cytokine, can downregulate PGHS-2 expression and inhibit prostaglandin production. Therefore, the aims of the current study were to determine the effects of IL-4 on PGHS-1 and PGHS-2 expression in amion-derived WISH cells treated with inflammatory cytokines and growth factors. In WISH cells, near-maximal production of the PGHS-2 mRNA occurred using 5 ng/ml EGF, 1 ng/ml IL-1beta or 50 ng/ml TNF-alpha. Time-course experiments determined that the PGHS-2 mRNA was induced maximally by these stimuli by 1 h. Pretreatment of WISH cells with IL-4 reduced PGHS-2 mRNA levels at 1 h by 67% in cells treated with EGF, 62% in cells treated with IL-1beta and 54% in cells treated with TNF-alpha. Pretreatment with IL-4 more effectively inhibited PGHS-2 expression than simultaneous addition with EGF or IL-1beta but not TNF-alpha. Immunoblot analysis showed a correlation between inhibition of mRNA levels and levels of PGHS-2 protein, although stimulation of PGHS-2 protein production by EGF was undetectable. Levels of PGHS-1 protein and mRNA remained unchanged in all experiments. Increased production of prostaglandin E2 (PGE2) in response to TNF-alpha and IL-1beta treatment was attenuated by IL-4 pretreatment, by 52% and 72%, respectively. No attenuation of EGF-stimulated PGE2 levels was seen. We conclude that IL-4 inhibits PGHS-2 mRNA and protein production in cytokine-stimulated WISH cells, but does not affect EGF-stimulated PGE2 production, suggesting that EGF can induce prostaglandin biosynthesis by a mechanism other than through increased PGHS-2 expression.
宫内感染期间前列腺素生物合成增加可能是引发早产的一种潜在机制。已知炎性细胞因子和生长因子可通过增加前列腺素内过氧化物H合酶(PGHS)-2的合成及活性来刺激前列腺素生成。白细胞介素-4(IL-4)是一种抗炎细胞因子,可下调PGHS-2表达并抑制前列腺素生成。因此,本研究的目的是确定IL-4对经炎性细胞因子和生长因子处理的羊膜来源WISH细胞中PGHS-1和PGHS-2表达的影响。在WISH细胞中,使用5 ng/ml表皮生长因子(EGF)、1 ng/ml白细胞介素-1β(IL-1β)或50 ng/ml肿瘤坏死因子-α(TNF-α)时,PGHS-2 mRNA的产量接近最大值。时间进程实验确定,这些刺激在1小时时可最大程度地诱导PGHS-2 mRNA。用IL-4预处理WISH细胞可使在1小时时经EGF处理的细胞中PGHS-2 mRNA水平降低67%,经IL-1β处理的细胞中降低62%,经TNF-α处理的细胞中降低54%。与同时添加EGF或IL-1β相比,用IL-4预处理能更有效地抑制PGHS-2表达,但对TNF-α无效。免疫印迹分析显示mRNA水平的抑制与PGHS-2蛋白水平之间存在相关性,尽管未检测到EGF对PGHS-2蛋白生成的刺激作用。在所有实验中,PGHS-1蛋白和mRNA水平均保持不变。IL-4预处理可使TNF-α和IL-1β处理后前列腺素E2(PGE2)产量的增加分别减弱52%和72%。未观察到IL-4对EGF刺激的PGE2水平的减弱作用。我们得出结论,IL-4可抑制细胞因子刺激的WISH细胞中PGHS-2 mRNA和蛋白的生成,但不影响EGF刺激的PGE2生成,这表明EGF可通过增加PGHS-2表达以外的机制诱导前列腺素生物合成。